NCT06483230 Implementation of IVS3 for Upper Limb Motor Recovery
| NCT ID | NCT06483230 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Neglect, Hemispatial |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2024-10-02 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2024-10-02 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study measures participant satisfaction and upper extremity function in outpatients with chronic stroke when exposed to the IVS3 device. Investigators hypothesize that treatment with the IVS3 device will be feasible and tolerable for use in the outpatient setting.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years old 2. English speaking 3. History of ischemic or hemorrhagic stroke ≥ 6 months prior to study enrolment 4. FMA-UE: 20 \< x \< 50 (moderate impairments) 5. With or without hemi spatial neglect Exclusion Criteria: 1. Spasticity or increased tone with MAS ≥3 in the upper extremity 2. Unable to communicate effectively or provide informed consent 3. Significant visual impairments 4. Concurrent occupational therapy being received outside of the study 5. Pregnant or incarcerated individuals
Contact & Investigator
Joan Stilling, MD,MS
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT06483230 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Neglect, Hemispatial. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06483230 currently recruiting?
Yes, NCT06483230 is actively recruiting participants. Contact the research team at zhy7009@med.cornell.edu for enrollment information.
Where is the NCT06483230 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06483230 clinical trial?
NCT06483230 is sponsored by Weill Medical College of Cornell University. The principal investigator is Joan Stilling, MD,MS at Weill Medical College of Cornell University. The trial plans to enroll 25 participants.